Phase 3 GAD Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Hoffmann-La Roche152 enrolled82 locationsNCT05271409

Recruiting

Phase 3

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

Anxiety DisordersGeneralized Anxiety Disorder (GAD)

Wayne State University90 enrolled1 locationNCT07123467